@article{70c8820e97bc48ec8051188d4d88d8a6,
title = "Major achievements in hepatocellular carcinoma",
author = "Jordi Bruix and Llovet, {Josep M.}",
note = "Funding Information: Our work is partly supported by a grant from the Instituto de Salud Carlos III (PI 06/132) and Acci{\'o}n Transversal en C{\'a}ncer. CIBEREHD is funded by the Instituto de Salud Carlos III. JB has received consulting or lecture fees or research grants from Bayer HealthCare Pharmaceuticals, Biocompatibles International, Eisai, Bristol-Myers Squibb, AstraZeneca, and Pharmexa. JML has received consulting or lecture fees or research grants from Bayer HealthCare Pharmaceuticals, Exelixis, Biocompatibles International, Bristol-Myers Squibb, and MDS Nordion.",
year = "2009",
doi = "10.1016/S0140-6736(09)60381-0",
language = "English",
volume = "373",
pages = "614--616",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Ltd.",
number = "9664",
}